Patent Foramen Ovale in Children With Migraine Headaches
| Status: | Completed |
|---|---|
| Conditions: | Migraine Headaches, Migraine Headaches |
| Therapuetic Areas: | Neurology |
| Healthy: | No |
| Age Range: | 6 - 17 |
| Updated: | 12/27/2017 |
| Start Date: | April 2008 |
| End Date: | March 2011 |
This study will be the first to provide data about the relationship between PFO and migraine
in children. By establishing the actual prevalence, we will better understand if PFO plays a
role in the occurence of pediatric migraine and, thus, provide the incentive to perform
additional studies evaluating whether PFO closure is an effective treatment option for
pediatric migraine. For children with migraine headaches, discovering novel and effective
treatments would be life altering.
in children. By establishing the actual prevalence, we will better understand if PFO plays a
role in the occurence of pediatric migraine and, thus, provide the incentive to perform
additional studies evaluating whether PFO closure is an effective treatment option for
pediatric migraine. For children with migraine headaches, discovering novel and effective
treatments would be life altering.
Specific Aim 1 Using contrast transthoracic echocardiography, compare the prevalence of a PFO
in children with migraine headache with the established incidence of PFO published for the
general population.
Specific Aim 2 Using contrast transcranial Doppler, examine the relationship between the
degree of right to left atrial shunting with the presence or absence of aura in children with
migraine.
in children with migraine headache with the established incidence of PFO published for the
general population.
Specific Aim 2 Using contrast transcranial Doppler, examine the relationship between the
degree of right to left atrial shunting with the presence or absence of aura in children with
migraine.
Inclusion Criteria:
- Greater than or equal to six years of age and less than 18 years of age.
- Diagnosis of migraine headache based on the International Headache Society Criteria.
- English speaking patients (and parent/guardians where appropriate).
- Signed informed consent/assent (as appropriate) given by patient, parent or legal
guardian.
Exclusion Criteria:
- Inability to cooperate with imaging studies.
- Known congenital heart disease.
- Parent or guardian is unwilling to have their child undergo contrast echocardiography.
We found this trial at
1
site
Click here to add this to my saved trials
